Clinical Trial Update: VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing VIT45 to oral iron for anemia in non-dialysis dependent chronic kidney disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• VIT45

Snippet

Sponsor: American Regent, Inc. | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2013-11-25